Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Oct 13, 2026 · Filed Oct 15, 2026
A Mdb Capital director paid $20K out of pocket for Mdb Capital shares. It was the first purchase in 9 months. Shares held went up 6% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$19,900
Shares × reported transaction price
<$25K
+5.9%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 9 months
Confirmed open-market purchases by the same insider in the available history
Yes
Compared with 27 earlier confirmed purchases
No other insider purchases within 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
Closed at $1.97 on Oct 13, 2026, at its 52-week low, after a 37% drop over the previous 30 trading days
52-week range $1.97 (Oct 13, 2026) to $4.60 (Oct 23, 2025), 0% of the way up, from 236 adjusted closes. 30 trading days earlier: $3.13 on Aug 25, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
Christopher A Marlett's largest purchase of MDBH in their filings since 2025
Compared with every open-market purchase and sale of this company in SEC filings since 2006. A fact about the record, not a signal to trade
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −2.8% | −0.4% | −2.4% |
Past results only. Not a forecast.
Insider filing
Traded Oct 26 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Oct 26 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Insider filing
Traded Oct 26 · filed 2 days later
Derivative exercise or conversion — not an open-market buy.
Christopher A Marlett, Co-Founder's past purchases, 90 days after disclosure: 15 buys, median −19.5 pts vs S&P 500, beat it 1 of 15 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.